🇺🇸 FDA
Patent

US 8524902

[1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases

granted A61PA61P1/16A61P11/06

Quick answer

US patent 8524902 ([1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/16, A61P11/06, A61P19/08, A61P25/00